Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1960 1
1964 1
1967 1
1968 3
1969 2
1970 1
1973 3
1974 5
1975 2
1976 2
1977 5
1978 10
1979 7
1980 10
1981 12
1982 6
1983 11
1984 6
1985 11
1986 7
1987 6
1988 4
1989 12
1990 5
1991 13
1992 12
1993 14
1994 17
1995 18
1996 17
1997 22
1998 30
1999 29
2000 40
2001 28
2002 54
2003 61
2004 67
2005 88
2006 107
2007 101
2008 138
2009 151
2010 180
2011 197
2012 228
2013 290
2014 370
2015 419
2016 428
2017 502
2018 536
2019 600
2020 725
2021 862
2022 759
2023 1
Text availability
Article attribute
Article type
Publication date

Search Results

6,473 results
Results by year
Filters applied: . Clear all
Page 1
CircITGB6 promotes ovarian cancer cisplatin resistance by resetting tumor-associated macrophage polarization toward the M2 phenotype.
Li H, Luo F, Jiang X, Zhang W, Xiang T, Pan Q, Cai L, Zhao J, Weng D, Li Y, Dai Y, Sun F, Yang C, Huang Y, Yang J, Tang Y, Han Y, He M, Zhang Y, Song L, Xia JC. Li H, et al. Among authors: sun f. J Immunother Cancer. 2022 Mar;10(3):e004029. doi: 10.1136/jitc-2021-004029. J Immunother Cancer. 2022. PMID: 35277458 Free PMC article.
6,473 results